Literature DB >> 18680145

Involvement of c-Src tyrosine kinase in SHP-1 phosphatase activation by Ang II AT2 receptors in rat fetal tissues.

Sergio E Alvarez1, Leonardo R Seguin, Rodrigo S Villarreal, Clara Nahmias, Gladys M Ciuffo.   

Abstract

Angiotensin II (Ang II) AT(2) receptors are abundantly expressed in rat fetal tissues where they probably contribute to development. In the present study we examine the effects of Ang II type 2 receptor stimulation on SHP-1 activation. Ang II (10(-7) M) elicits a rapid and transient tyrosine phosphorylation of SHP-1, maximal at 1 min, in a dose-dependent form, blocked by the AT(2) antagonist, PD123319. SHP-1 phosphorylation is followed in time by tyrosine dephosphorylation of different proteins, suggesting a sequence of events. Ang II induces association of SHP-1 to AT(2) receptors as shown by co-immunoprecipitation, Western blot and binding assays. SHP-1 activity was determined in immunocomplexes obtained with either anti-AT(2) or anti-SHP-1 antibodies, after Ang II stimulation (1 min), in correlation with the maximal level of SHP-1 phosphorylation. Interestingly, following receptor stimulation (1 min) c-Src was associated to AT(2) or SHP-1 immunocomplexes. Preincubation with the c-Src inhibitor PP2 inhibited SHP-1 activation and c-Src association, thus confirming the participation of c-Src in this pathway. We demonstrated here for the first time the involvement of c-Src in SHP-1 activation via AT(2) receptors present in an ex vivo model expressing both receptor subtypes. In this model, AT(2) receptors are not constitutively associated to SHP-1 and SHP-1 is not constitutively activated. Thus, we clearly establish that SHP-1 activation, mediated by the AT(2) subtype, involves c-Src and precedes protein tyrosine dephosphorylation, in rat fetal membranes. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18680145     DOI: 10.1002/jcb.21866

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

1.  Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells.

Authors:  Young H Lee; Ognoon Mungunsukh; Rebecca L Tutino; Ana P Marquez; Regina M Day
Journal:  J Cell Sci       Date:  2010-04-20       Impact factor: 5.285

2.  G alpha 12 inhibits alpha2 beta1 integrin-mediated Madin-Darby canine kidney cell attachment and migration on collagen-I and blocks tubulogenesis.

Authors:  Tianqing Kong; Daosong Xu; Wanfeng Yu; Ayumi Takakura; Ilene Boucher; Mei Tran; Jordan A Kreidberg; Jagesh Shah; Jing Zhou; Bradley M Denker
Journal:  Mol Biol Cell       Date:  2009-09-23       Impact factor: 4.138

3.  Angiotensin II type 2 receptor-stimulated activation of plasma prekallikrein and bradykinin release: role of SHP-1.

Authors:  Liping Zhu; Oscar A Carretero; Jiang Xu; Luchen Wang; Pamela Harding; Nour-Eddine Rhaleb; James J Yang; Colin Sumners; Xiao-Ping Yang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-20       Impact factor: 4.733

Review 4.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

Review 5.  Cardiac insulin resistance and microRNA modulators.

Authors:  Lakshmi Pulakat; Annayya R Aroor; Rukhsana Gul; James R Sowers
Journal:  Exp Diabetes Res       Date:  2011-07-31

6.  The SHP-1 protein tyrosine phosphatase negatively modulates Akt signaling in the ghrelin/GHSR1a system.

Authors:  Maria Lodeiro; Begoña O Alén; Carlos S Mosteiro; Daniel Beiroa; Rubén Nogueiras; Marily Theodoropoulou; María Pardo; Rosalía Gallego; Yolanda Pazos; Felipe F Casanueva; Jesus P Camiña
Journal:  Mol Biol Cell       Date:  2011-09-07       Impact factor: 4.138

7.  How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations?

Authors:  Marie-Odile Guimond; Nicole Gallo-Payet
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-19       Impact factor: 5.555

8.  Tumoral prostate shows different expression pattern of somatostatin receptor 2 (SSTR2) and phosphotyrosine phosphatase SHP-1 (PTPN6) according to tumor progression.

Authors:  Ariel Ernesto Cariaga-Martinez; María Angelica Lorenzati; Mario Alejandro Riera; Marisa Angelica Cubilla; Andrés De La Rossa; Ernesto Martín Giorgio; María Mercedes Tiscornia; Esteban Mariano Gimenez; María Eugenia Rojas; Bárbara Julieta Chaneton; Dora Isabel Rodríguez; Pedro Darío Zapata
Journal:  Adv Urol       Date:  2009-04-12

9.  Angiotensin (ang) 1-7 inhibits ang II-induced atrial fibrosis through regulating the interaction of proto-oncogene tyrosine-protein kinase Src (c-Src) and Src homology region 2 domain-containing phosphatase-1 (SHP-1)).

Authors:  Li Lu; Li Cao; Yihao Liu; Yunlin Chen; Jinqi Fan; Yuehui Yin
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.